Not Found
Digital Seminar

Neuromuscular & Neurodegenerative Disorders

Bonita Gordon, MSN, RN, APRN-BC, CNRN
5 Hours 47 Minutes
Audio and Video
Product Code:
Media Type:
Digital Seminar


Management Strategies for:

  • Multiple Sclerosis
  • Alzheimer’s Disease
  • Myasthenia Gravis
  • Parkinson’s Disease
  • Guillain-Barré Syndrome
  • Amyotrophic Lateral Sclerosis

Neuromuscular & Neurodegenerative Disorders remain the nation’s leading cause of disability. They are devastating and costly. There is a need to provide early diagnosis and apply effective therapies for these disorders. Join expert, Bonita Gordon, MSN, RN, APRN-BC, CNRN, and gain new insights into the pathophysiologic changes, clinical manifestations, and diagnostic studies for each of these disorders. Learn the latest in innovative medications that are geared to slow or stop the disorder progression.

Through an engaging presentation style and enlightening case studies, Bonita will enhance your knowledge regarding current practice issues. The evidence-based content is valuable to all healthcare providers caring for patients with neuromuscular and neurodegenerative disorders.




NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing and passing the on-line post-test evaluation). 

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards

Nurses - California (Self-Study)

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 13305 for 5.5 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Nurses - Florida (Self-Study)

CE Broker

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 5.5 self-study contact hours.

** Florida Participants Only: To automatically be reported to CE Broker, after completing and passing the online post-test/evaluation, please contact You will need to provide the full title of the activity, speaker name, date of live broadcast, your name and your license number in the email.

Nurses - Iowa (Self-Study)

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 7.0 self-study contact hours. Please email with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.

Florida Occupational Therapists & Occupational Therapy Assistants

CE Broker

PESI, Inc. is an approved provider with the Florida Board of Occupational Therapy. Provider Number #50-399. This course qualifies for 5.8 self-study continuing education credits.

Physical Therapists & Physical Therapist Assistants

This self-study course consists of 5.75 clock hours of instruction that is applicable for physical therapists. CE requirements for physical therapists vary by state/jurisdiction. Please retain the certificate of completion that you receive and use as proof of completion when required.

California Physical Therapists & Physical Therapist Assistants

PESI, Inc. is recognized by the Physical Therapy Board of California as an approval agency to approve providers. This self-study lecture qualifies for 5.75 continuing competency hours.

Illinois Physical Therapists & Physical Therapist Assistants

PESI, Inc. is a Registered Physical Therapy Continuing Education Sponsor through the State of Illinois Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 216.000270. This self-study course qualifies for 5.5 CE credit hours.

New York Physical Therapists & Physical Therapist Assistants

PESI, Inc. is recognized by the New York State Education Department, State Board for Physical Therapy as an approved provider for physical therapy and physical therapy assistant continuing education. This self-study course qualifies for 7.0 contact hours.

Speech-Language Pathologists & Audiologists

This course contains 5.5 hours of self-study continuing education. It was not offered for ASHA CEUs. Please retain your certificate of completion. If audited for ASHA Certification Maintenance, you can submit this certificate of completion at that time. For state licensure, teacher certification renewal, or other credential renewal, contact those agencies for information about your reporting responsibilities and requirements.

California Speech-Language Pathologists & Audiologists

PESI, Inc. is an approved provider with the California Speech-Language Pathology and Audiology Board, #PDP 319. This course meets the qualifications for 5.5 hours of self-study continuing professional development credit for Speech-Language Pathologists or Audiologists, as required by the California Speech-Language Pathology and Audiology Board.

Θ Other Professions (Self-Study)

This self-study activity qualifies for 5.75 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Bonita Gordon, MSN, RN, APRN-BC, CNRN Related seminars and products

Bonita Gordon practiced nursing close to 30 years, focusing primarily in the areas of neuroscience and acute care nursing. Bonita worked as a staff educator on the neuroscience/orthopedic/trauma, rehabilitation and medical/surgical units, where she presented lectures on acute and critical care processes. Bonita's expertise in neuroscience disease processes includes knowledge acquired during her work as a neuroscience critical care nurse and as a clinical nurse specialist in neurosurgery and neurology. After completing her post-master's certification as an adult nurse practitioner at St. Louis University, Bonita continued to hone her skills in her practice at a university's neuroscience center.

Bonita has presented extensively on neuroscience diseases, diabetes and acute care. She is an active member of the American Association of Neuroscience Nurses (AANN), the American College of Nurse Practitioners and Sigma Theta Tau. Bonita serves as a national committee member for the American Association of Neuroscience Nurses. She has published extensively in peer-reviewed journals including Journal of Neuroscience Nursing, Journal of Oncology Nursing, and Journal of Nursing Quality Care and developed content on the spine and spinal problems for the AANN certification review course.

Target Audience

Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physical Therapists, Physical Therapist Assistants, Occupational Therapists, Occupational Therapy Assistants, Speech Language Therapists, Audiologists, Pharmacists



Multiple Sclerosis

  • Four Classifications of MS
  • Look for the Oligoclonal Bands
  • ABCs of Medication Management
    • Immunomodulating disease-modifying agents
    • Corticosteroids
    • Antispasmotic
    • Anticholinergic
    • Antiviral
    • CNS stimulant
    • Antiepileptic
    • Antidepressant
    • Beta blocker
    • Natalizumab
  • Manage the Symptoms
    • Optic neuritis
    • Fatigue
    • Ataxia

Alzheimer’s Disease Diagnosis

  • Staging the Disease
  • Disease-Specific Treatment
    • Drug therapy to slow the progression
    • Treatment of behavioral manifestations
  • Provide a Therapeutic Environment
    • Participate in activities of daily living
    • Monitor and protect from injury
    • Community resources
    • Caregiver stress

Myasthenia Gravis

  • Neuromuscular Junction Disorder
    • Autoimmune process
    • Reduced acetyl-choline receptor sites
  • Doing the Edrophonium Test
    • Evaluate response to edrophonium (telsilon)
    • Short-acting anticholinesterase inhibitor
    • Increase neurotransmission
  • Pathways to Recovery
    • Medications – anticholinesterase inhibitors, corticosteroids, immunosppressive agents
    • Thymectomy
    • Plasmapheresis or intravenous immunoglobulin

Parkinson’s Disease

  • Degeneration of Substantia Nigra
    • Basal ganglia degeneration
    • Deficiency of dopamine
  • Know the Symptoms “T-R-A-P”
    • Tremors - resting
    • Rigidity – cogwheel jerking
    • Akinesia - bradykinesia
    • Posture – stooped, shuffling gait
  • Treatment Options
    • Medications - dopaminergics, anticholinergics, dopamine agonist, MAO-B inhibitor, COMT inhibitors, antiviral
    • Neuroprotective agents
    • Deep brain stimulation

Guillain-Barré Syndrome

  • Syndrome Variants
    • Ascending
    • Pure-motor
    • Descending
    • Miller-Fisher Syndrome
  • Treatment Options
    • Plasmapheresis
    • Intravenous immunoglobulin

Amyotrophic Lateral Sclerosis

  • Degeneration of Motor Neurons
    • Excitotoxic damage
    • Defect in transport proteins
  • Slow and Progressive Weakness
    • Muscle atrophy
    • Paralysis
    • Respiratory failure
    • Death
  • Symptom Management
  • Alternatives
    • Megadose vitamin
    • Pancreatic enzymes
    • Wheat germ
    • Snake venom
    • Bee pollen




  • Explain the appropriate medication management in the care of the multiple sclerosis patient.
  • Compare the latest options to manage the various symptoms of the multiple sclerosis patient.
  • Illustrate how to provide a therapeutic environment for the Alzheimer’s disease patient.
  • Explain the latest drug therapy options available to slow down the progression of Alzheimer’s disease.
  • Diagram the pathways to recovery for the patient with myasthenia gravis.
  • Analyze treatment considerations for the patient with Parkinson’s disease.
  • Contrast the syndrome variants for the patient with Guillain-Barré Syndrome.
  • Develop symptomatic management for the patient with amyotrophic lateral sclerosis.




Overall:      5

Total Reviews: 1

Please wait ...

Back to Top